These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15721563)

  • 41. Protect effect of bicyclol on cisplatin-induced nephrotoxicity in mice.
    Yu YN; Chen H; Li Y
    Arch Toxicol; 2009 Apr; 83(4):381-7. PubMed ID: 18956176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of ebselen for radioprotection in cultured cells and mice.
    Tak JK; Park JW
    Free Radic Biol Med; 2009 Apr; 46(8):1177-85. PubMed ID: 19439217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin.
    Mukherjea D; Whitworth CA; Nandish S; Dunaway GA; Rybak LP; Ramkumar V
    Neuroscience; 2006 May; 139(2):733-40. PubMed ID: 16464536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity.
    Sung CYW; Hayase N; Yuen PST; Lee J; Fernandez K; Hu X; Cheng H; Star RA; Warchol ME; Cunningham LL
    Sci Adv; 2024 Jul; 10(30):eadk9878. PubMed ID: 39047106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
    Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
    Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cochlear structure and function after round window application of ototoxins.
    Bauer CA; Brozoski TJ
    Hear Res; 2005 Mar; 201(1-2):121-31. PubMed ID: 15721567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ebselen effects on MPTP-induced neurotoxicity.
    Dhanasekaran M; Uthayathas S; Karuppagounder SS; Parameshwaran K; Suppiramaniam V; Ebadi M; Brown-Borg HM
    Brain Res; 2006 Nov; 1118(1):251-4. PubMed ID: 16956591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals.
    Dehne N; Lautermann J; Petrat F; Rauen U; de Groot H
    Toxicol Appl Pharmacol; 2001 Jul; 174(1):27-34. PubMed ID: 11437646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ebselen increases cytosolic free Ca2+ concentration, stimulates glutamate release and increases GFAP content in rat hippocampal astrocytes.
    Salazar M; Pariente JA; Salido GM; González A
    Toxicology; 2008 Feb; 244(2-3):280-91. PubMed ID: 18237838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose-dependent protection on cisplatin-induced ototoxicity - an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model.
    Lorito G; Hatzopoulos S; Laurell G; Campbell KC; Petruccelli J; Giordano P; Kochanek K; Sliwa L; Martini A; Skarzynski H
    Med Sci Monit; 2011 Aug; 17(8):BR179-186. PubMed ID: 21804453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.
    Berglin CE; Pierre PV; Bramer T; Edsman K; Ehrsson H; Eksborg S; Laurell G
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1547-56. PubMed ID: 21533919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes.
    Kang SM; Lim S; Song H; Chang W; Lee S; Bae SM; Chung JH; Lee H; Kim HG; Yoon DH; Kim TW; Jang Y; Sung JM; Chung NS; Hwang KC
    Eur J Pharmacol; 2006 Mar; 535(1-3):212-9. PubMed ID: 16516885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ebselen attenuates cochlear damage caused by acoustic trauma.
    Pourbakht A; Yamasoba T
    Hear Res; 2003 Jul; 181(1-2):100-8. PubMed ID: 12855368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs.
    van Ruijven MW; de Groot JC; Hendriksen F; Smoorenburg GF
    Hear Res; 2005 May; 203(1-2):112-21. PubMed ID: 15855036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of antioxidants and other agents to prevent cisplatin ototoxicity.
    Rybak LP; Whitworth C; Somani S
    Laryngoscope; 1999 Nov; 109(11):1740-4. PubMed ID: 10569399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of ebselen on the toxicity of cisplatin in LLC-PK1 cells.
    Baldew GS; Boymans AP; Mol JG; Vermeulen NP
    Biochem Pharmacol; 1992 Jul; 44(2):382-7. PubMed ID: 1642650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.
    Borse V; Al Aameri RFH; Sheehan K; Sheth S; Kaur T; Mukherjea D; Tupal S; Lowy M; Ghosh S; Dhukhwa A; Bhatta P; Rybak LP; Ramkumar V
    Cell Death Dis; 2017 Jul; 8(7):e2921. PubMed ID: 28703809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide.
    Saleh S; El-Demerdash E
    Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):91-7. PubMed ID: 15998355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.